SD
Cleo Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lagevrio® (molnupiravir) | COVID-19 (Antiviral) | Approved |
| Oxbryta® (voxelotor) | Sickle Cell Disease | Approved |
| Kyprolis® (carfilzomib) | Multiple Myeloma | Approved |
| Vibativ® (telavancin) | Bacterial Infections | Approved |
| Yupelri® (revefenacin) | COPD | Approved |